Itraconazole (also known as Sporanox®) is an anti-fungal triazole compound first approved by the FDA in 1992 for the treatment of systemic fungal infections1. Itraconazole is well tolerated and is broadly effective against multiple types of fungus, including Candida and Aspergillus species, Cryptococcus neoformans, and many others2. The anti-fungal activity of itraconazole is mediated through […]